Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Lupus ; 28(1): 123-128, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30442061

ABSTRACT

BACKGROUND/PURPOSE: Lupus nephritis (LN) usually develops within the first years of systemic lupus erythematosus (SLE) onset and rarely after that. There are scarce studies comparing early- versus late-onset nephritis (before versus after five years of SLE diagnosis). The aim of this study was to compare the severity and long-term outcome (after 7 years) in these two, late-onset and early-onset, nephritis groups. METHODS: This study included 93 patients from rheumatology tertiary centers from Brazil and Italy, all of them with biopsy-proven LN with > 7 years follow-up. Patients were divided in two groups: early-onset nephritis ( n = 75) and late-onset nephritis ( n = 18). Clinical and laboratorial data were obtained using a standardized electronic chart database protocol carried out at 1-6 months interval and established in 2000. Patients >50 years or with concomitant autoimmune diseases were excluded. Variables evaluated at the LN presentation were Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), creatinine, albumin, anti-DNA positivity and nephritis class. Variables evaluated at the long-term outcome (after 7 years) were Systemic Lupus International Collaborating Clinics Damage Index (SDI), creatinine, dialysis and mortality. RESULTS: The average time of LN presentation was 10.94 ± 3.73 years for the late-onset and 1.20 ± 1.60 years for the early-onset group. Their similar nephritis duration (12.44 ± 3.2 versus 13.28 ± 4.03 years, p = 0.41) and comparable mean ages (49.17 ± 9.9 versus 44.11 ± 10.8 years old, p = 0.06) allow a more accurate comparison. Regarding severity, late-onset was similar to early-onset group: SLEDAI (8 (range: 6-22) versus 12 (range: 2-24), p = 0.47), creatinine (1.36 ± 0.94 versus 1.36 ± 1.13 mg/dl, p = 0.99); albumin (2.84 ± 0.65 versus 2.59 ± 0.84 mg/dl, p = 0.30); proteinuria (3.77 ± 2.18 versus 5.01 ± 4.51 g/vol, p = 0.26); proliferative nephritis (44% ( n = 8) versus 60% ( n = 45), p = 0.23). There was also no difference in the long-term outcomes between groups: SDI (1 (range: 0-5) versus 0.5 (range: 0-5), p = 0.27); creatinine (2.04 ± 2.38 versus 1.69 ± 2.26 mg/dl, p = 0.56); dialysis (22% ( n = 4) versus 13% ( n = 10), p = 0.46) and mortality (0% ( n = 0) versus 12% ( n = 9), p = 0.19). CONCLUSION: This study provides novel evidence of comparable long-term outcomes between late-onset and early-onset nephritis, which is most likely explained by the observation that at presentation, the clinical, laboratorial and histological features of late-onset and early-onset nephritis are similar. This suggests that there should be no distinct treatment targets and therapeutic interventions for the late- and early-onset groups.


Subject(s)
Lupus Nephritis/pathology , Lupus Nephritis/physiopathology , Adult , Age of Onset , Biopsy , Brazil , Disease Progression , Female , Humans , Italy , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Young Adult
2.
Lupus ; 27(10): 1735-1741, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30045666

ABSTRACT

Introduction The Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) is a patient-reported instrument for the assessment of disease activity in systemic lupus erythematosus (SLE). The aims of the present study are translation, cultural adaptation and validation of an Italian version: the SLAQit. Methods The process of translation and cultural adaptation followed published guidelines. SLAQit was pretested in a group of 35 SLE patients to evaluate acceptability, comprehension and feasibility. Internal consistency, test-retest validity and external validity were tested on consecutive SLE patients attending the clinic. Results In total, 135 SLE patients were enrolled in this study. The pilot test provided a 99.9% response rate and demonstrated feasibility and comprehensibility of the questionnaire. A good internal consistency was found among the three components of the score (SLAQ score, numerical rating scale (NRS), patient global assessment question (PGA); α = 0.79). SLAQit showed very high reliability (test-retest α > 0.8). NRS and PGA showed a strong positive correlation with both Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) ( p = 0.002 and p < 0.001, respectively) and European Consensus Lupus Measurement (ECLAM) scores ( p = 0.01 and p < 0.001, respectively), while the SLAQ score did not. A significant agreement was observed between the physician's intention to treat and both the NRS and PGA scores, while no significant association was reported with the SLAQ score. Conclusions SLAQit was demonstrated to be a reliable and valid instrument for self-assessment of disease activity in SLE patients.


Subject(s)
Cultural Characteristics , Health Knowledge, Attitudes, Practice/ethnology , Lupus Erythematosus, Systemic/diagnosis , Patient Reported Outcome Measures , Translating , White People/psychology , Adult , Comprehension , Feasibility Studies , Female , Humans , Italy/epidemiology , Lupus Erythematosus, Systemic/ethnology , Lupus Erythematosus, Systemic/psychology , Lupus Erythematosus, Systemic/therapy , Male , Middle Aged , Pilot Projects , Predictive Value of Tests , Prognosis , Reproducibility of Results , Severity of Illness Index
3.
Scand J Rheumatol ; 45(5): 408-11, 2016 Oct.
Article in English | MEDLINE | ID: mdl-26948487

ABSTRACT

OBJECTIVES: Vascular involvement is a key feature of systemic sclerosis (SSc). Vascular changes are central to the pathogenesis of the disease and the assessment of vascular involvement has a prognostic value. This assessment therefore has a pivotal role in the management of SSc patients. The aim of our study was to evaluate post-occlusive reactive hyperaemia (PORH) in consecutive SSc patients and to test whether a PORH test might be a useful tool for the early diagnosis of SSc. METHOD: Between April 2011 and April 2015, 60 consecutive SSc patients (mean age 56 ± 15 years, females:males = 18:1) were enrolled in the study. The patients were divided into those with full-blown SSc (n = 50) and those with very early diagnosis of SSc (VEDOSS) (n = 10) according to the literature. Laser speckle contrast analysis (LASCA) was used to assess PORH. RESULTS: A statistically significant difference was detected in the post-ischaemic hyperaemic peak flow between VEDOSS and established SSc (424% vs. 137%, p = 0.0011). PORH peak flow decreased according to the capillaroscopic pattern (early = 419%, active = 163%, late = 145%, p = 0.0027). Moreover, a correlation between capillary density and peak flow was revealed (rho = 0.33, p < 0.01). CONCLUSIONS: These data show a different pattern of vascular involvement in VEDOSS compared to established disease that mirrors capillaroscopic changes. Functional features of very early and established disease seem to be the physiological counterpart of abnormalities detected by capillaroscopy. The POHR test might be a useful aid for further characterization of vascular involvement in SSc. In particular, blunted POHR might prove a tool to separate pre-clinical from full-blown SSc.


Subject(s)
Hyperemia/diagnostic imaging , Microscopic Angioscopy , Perfusion Imaging , Scleroderma, Systemic/diagnostic imaging , Adult , Aged , Antibodies, Antinuclear/immunology , Autoantibodies/immunology , DNA Topoisomerases, Type I , Early Diagnosis , Esophageal Diseases/epidemiology , Female , Humans , Hyperemia/drug therapy , Hyperemia/epidemiology , Hyperemia/immunology , Hyperlipidemias/epidemiology , Hypertension/epidemiology , Hypertension, Pulmonary/epidemiology , Lung Diseases, Interstitial/epidemiology , Male , Middle Aged , Nuclear Proteins/immunology , Scleroderma, Systemic/drug therapy , Scleroderma, Systemic/epidemiology , Scleroderma, Systemic/immunology , Vasodilator Agents/therapeutic use , Young Adult
4.
Clin Exp Rheumatol ; 33(2 Suppl 89): S-145-54, 2015.
Article in English | MEDLINE | ID: mdl-26016767

ABSTRACT

Herewith we provide our annual digest of the recent literature on systemic vasculitides. In this manuscript, we reviewed all the articles published during the last 12 months on large-, medium- and small-vessel vasculitis and selected the most relevant studies regarding the epidemiology, pathogenesis and management of systemic vasculitis. In particular, we focused the attention on giant cell arteritis, ANCA-associated vasculitis and cryoglobulinaemia.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Cryoglobulinemia , Giant Cell Arteritis , Takayasu Arteritis , Humans
6.
Clin Exp Rheumatol ; 30(3 Suppl 72): S69-72, 2012.
Article in English | MEDLINE | ID: mdl-23009765

ABSTRACT

OBJECTIVES: The aim of the present study was to retrospectively assess the prevalence of neurological involvement and the clinical patterns of presentation in a monocentric cohort of patients with BD, who have been followed in the last twenty years at our centre. METHODS: One hundred and seventeen patients were retrospectively studied. The male/female ratio was 1.6:1, with a mean disease duration of 11±5 years. Their mean age was 42±9 years (min:18, max:77), while the mean age at disease onset was 25±4 years (min:10, max:58). The mean ± SD duration of follow-up at our centre was 7±2 (min:1, max:11) years. RESULTS: Neurological involvement was observed in 38% (44 patients, 36 males and 8 females; mean age at onset 25±4 years). Organic brain involvement, demonstrated by MRI was due to ischaemic pons-mesencephalon lesions in 19 patients and to meningoencephalitis with brainstem involvement in 16. Peripheral nervous system involvement was confirmed by electroneuromyographic study in 4 patients, and consisted of peripheral neuropathy prominent in the lower extremities in all cases; we have also observed only 2 cases of endocranial hypertension and 3 BD patients suffering from pulsatile, severe headache, without abnormal neurological examination, responding only to medium-high doses of steroids. Excluding peripheral neuropathy and isolated headache, the onset of CNS involvement (total prevalence: 32% of the cohort) was observed in 2 patients within the first year from the onset of BD, in 4 cases between the first and the third year, in 24 between the third and the fifth year, 7 between the fifth and the tenth year; none presented a CNS involvement after the first 10 years of disease. CONCLUSIONS: Neuro-BD is more frequent in young males and it never represents a presenting feature of the disease. The most frequent time of onset of neurological involvement seems to be within the first 10 years of disease. Since neurological involvement may result in severe functional disability or be a life-threatening disease, a careful follow-up during the first years after onset is recommended.


Subject(s)
Behcet Syndrome/epidemiology , Peripheral Nervous System Diseases/epidemiology , Adult , Age Factors , Age of Onset , Aged , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/epidemiology , Chi-Square Distribution , Disease Progression , Electrodiagnosis , Female , Humans , Italy/epidemiology , Magnetic Resonance Imaging , Male , Middle Aged , Peripheral Nervous System Diseases/diagnosis , Prevalence , Prognosis , Retrospective Studies , Risk Assessment , Risk Factors , Sex Factors , Time Factors , Young Adult
7.
Trop Anim Health Prod ; 37(7): 559-72, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16450862

ABSTRACT

To determine the relationship between first service conception rate (FSC) and the postpartum period (PP), 6160 calvings from 2250 crossbred dual-purpose cows were analysed. The effects of breed predominance (BT: Bos taurus and BI: Bos indicus), season of service (dry, intermediate and humid), parity (1 or 2 and more), agroecological region (Sub-humid and Dry Tropical Forest) and milk production were studied. The postpartum period was grouped according to the calving-first service interval as G1 < or = 60 days (n = 1889); G2 > 60 < or = 90 days (n = 1436); G3 > 90 < or = 120 days (n = 1030); and G4 > 120 days (n = 1805). Data were analysed by chi-squared test. The overall mean for FSC was 58.2% and was lower in G1 (p < 0.01). All PP showed a breed effect on FSC, with mean values of 61.6% and 53.3% for BI and BT, respectively. Season of service also affected FSC, which was significantly lower during the humid period: 51.2% versus 57.4% and 61.5% for the intermediate and dry periods (p < 0.01), respectively. Parity and environmental effects were not observed on FSC. Levels of milk yield did influence the FSC, which decreased from 66.7% and 61.0% for milk yields of < 1500 kg and between 1501 and 2000 kg to 46.0% in milk yields > 2000 kg (p < 0.01).


Subject(s)
Cattle/physiology , Crosses, Genetic , Fertility/physiology , Lactation/physiology , Sucking Behavior/physiology , Animals , Animals, Suckling , Dairying/methods , Female , Milk/metabolism , Parity , Postpartum Period , Pregnancy , Seasons , Tropical Climate
8.
C R Seances Acad Sci III ; 294(17): 867-70, 1982 May 10.
Article in French | MEDLINE | ID: mdl-6809249

ABSTRACT

Preovulatory LH surges were induced and synchronized in 12 Alpine goats during the anoestrus season using a progestagen-PMSG treatment. Onsets of oestrus, plasma LH levels and numbers of ovulations were recorded. During the preovulatory surge, frequencies of blood sampling were such (1 per hour in 8 goats and 1 each 4 min. in 4 other goats) as to allow for the first time a precise description of this biological event in the goat. Results may be summarized as follows: (1) Plasma LH levels were low (less than 1 ng/ml) and constant during the hours preceding the surge, (2) the onset of LH surge preceded by 2 hrs, on the average, that of oestrus behaviour, (3) preovulatory surges presented a definite pulsatility when maximum levels were reached, (4) no positive relationship was found between the magnitude of the surge and the corresponding number of ovulation, (5) in two animals, the LH surge was definitely biphasic, each peak presenting serveral pulses of secretion.


Subject(s)
Anestrus , Estrus , Goats/physiology , Luteinizing Hormone/metabolism , Anestrus/drug effects , Animals , Estrus/drug effects , Female , Gonadotropins, Equine/pharmacology , Kinetics , Luteinizing Hormone/blood , Ovulation , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...